- $991.39m
- $3.98bn
- $802.55m
- 43
- 85
- 59
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,017 | 1,065 | 1,096 | 967 | 803 |
Cost of Revenue | |||||
Gross Profit | 842 | 871 | 893 | 772 | 607 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 746 | 717 | 721 | 681 | 702 |
Operating Profit | 271 | 349 | 375 | 286 | 100 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 117 | 209 | 250 | 155 | -82.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 97.7 | 168 | 196 | 118 | -66.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 86.2 | 149 | 183 | 117 | -83.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 86.2 | 149 | 183 | 117 | -83.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.9 | 3.27 | 4.04 | 2.94 | -2.04 |